Brent Hatzis-Schoch, See Remarks at Black Diamond Therapeutics, Inc. (BDTX), sold 15,295 shares at $29.92 ($506K) on 2021-01-12, disclosed to the SEC on 2021-01-14.
Open-market sale of $506k BDTX by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.92 | 2,048 | $61K | 12.1% |
| 2 | $29.92 | 2,048 | $61K | 12.1% |
| 3 | $30.50 | 1,669 | $51K | 10.1% |
| 4 | $30.50 | 1,669 | $51K | 10.1% |
| 5 | $31.91 | 147 | $5K | 0.9% |
| 6 | $32.50 | 103 |
| $3K |
| 0.7% |
| 7 | $34.13 | 100 | $3K | 0.7% |
| 8 | $36.00 | 7,511 | $270K | 53.4% |
| Total | $33.10 avg | 15,295 | $506K | 100% |
| Filing → |
| BDTX | SELL | 2021-03-16 | $215K | — | Filing → |
| BDTX | SELL | 2021-02-12 | $214K | — | Filing → |
| BDTX | SELL | 2020-12-16 | $285K | — | Filing → |